SCHEMBL1406992

SCHEMBL1406992

CC(C)(C)n1ncc(C(=O)NC23CC4CC(CC(C4)C2)C3)c1N1CCC(O)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.43
CASR P41180 5/20 0.42
HSD11B1 P28845 3/20 0.39
PDE4A P27815 1/20 0.39
HSD17B3 P37058 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CNR2 P34972 3/20 0.38
CNR1 P21554 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
TSHR P16473 1/20 0.38
ALOX12 P18054 1/20 0.38
HTT P42858 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1407130 0.94 POLB (0.45) POLBCASRHSD11B1PDE4AHSD17B3
SCHEMBL1406965 0.86 POLB (0.51) POLBCASRHSD11B1PDE4AHSD17B3
SCHEMBL1406815 0.86 POLB (0.51) POLBCASRHSD11B1PDE4AHSD17B3
SCHEMBL1407081 0.85 POLB (0.46) POLBCASRMEN1KMT2ACNR2
SCHEMBL1406991 0.82 LMNA (0.44) HSD11B1HPGDHTT
SCHEMBL3690093 0.80 CASR (0.49) CASRCNR2CNR1KDM4EALDH1A1
SCHEMBL1406598 0.80 POLB (0.53) POLBCASRHSD11B1PDE4AHSD17B3
SCHEMBL20108780 0.79 POLB (0.45) POLBCASRMEN1KMT2ACNR2
SCHEMBL12809574 0.78 HSD11B1 (0.33) HSD11B1MEN1KMT2AKDM4EALDH1A1
SCHEMBL1407100 0.77 POLB (0.51) POLBCASRMEN1KMT2ACNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1999114-B1 PYRAZOLES AS 11-BETA-HSD-1 HOFFMANN LA ROCHE (CH) 2015-07-22 EP disclosed
EP-2295411-A1 Pyrazoles as 11-beta-hsd-1 F. Hoffmann-La Roche AG (CH) 2011-03-16 EP disclosed
US-7728029-B2 Adamantyl-pyrazole carboxamides as inhibitors of 11β-hdroxysteroid dehydrogenase HOFFMANN-LA ROCHE INC. (US) 2010-06-01 US disclosed
EP-1999114-A2 PYRAZOLES AS 11-BETA-HSD-1 F. Hoffmann-la Roche AG (CH) 2008-12-10 EP disclosed
WO-2007107470-A2 PYRAZOLES AS 11-BETA-HSD-1 F. HOFFMANN-LA ROCHE AG (CH) 2007-09-27 WO disclosed
US-20070225280-A1 Adamantyl-pyrazole carboxamides as inhibitors of 11B-hydroxysteroid dehydrogenase ANDERSON KEVIN WILLIAM 2007-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225280-A1 Adamantyl-pyrazole carboxamides as inhibitors of 11B-hydroxysteroid dehydrogenase HSD3B2, HSD3B1, HSD17B2 POLB 1549/4885CASR 4691/4885HSD11B1 6/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.